In comparison, the aforementioned study of ploidy status and survival outcome in human breast cancer patients with and without BRCA2 mutation presented data from almost 3,000 patients that was acquired over a 50-year period [16]. This evidence concerns the gene BRCA2 and breast carcinoma.